Age-dependent decrease in serum soluble interferon-gamma receptor (sIFN-gammaR) in healthy Japanese individuals;

Yoshihiro Okamoto1, Kyoko Seta, Izumi Nakajo

  • 1Laboratory of Immunology and Microbiology, Faculty of Pharmacy, Chiba Institute of Science, Choshi, Chiba, Japan. yokamoto@cis.ac.jp

Insights

Serum soluble interferon-gamma receptor (sIFN-gammaR) levels are higher in healthy children than adults. Age-matched controls are crucial for interpreting pediatric sIFN-gammaR levels in clinical diagnostics.

Area of Science:

  • Immunology
  • Pediatrics
  • Clinical Chemistry

Background:

  • The clinical utility of serum soluble interferon-gamma receptor (sIFN-gammaR) requires established reference values.
  • Pediatric reference ranges for sIFN-gammaR are currently unavailable, hindering diagnostic applications.

Purpose of the Study:

  • To determine the normal serum sIFN-gammaR levels in healthy Japanese children.
  • To establish age-specific reference values for pediatric sIFN-gammaR.
  • To assess the preliminary diagnostic utility of sIFN-gammaR in pediatric hemolytic uremic syndrome (HUS).

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was employed to measure serum sIFN-gammaR levels.
  • Serum samples were collected from healthy Japanese children (0-14 years) and adults (>15 years).
  • Statistical analysis was performed to compare sIFN-gammaR levels between age groups.

Main Results:

  • Serum sIFN-gammaR levels were significantly higher in children compared to adults (p < 0.01).
  • A total of 104 healthy individuals (children and adults) were analyzed.
  • Preliminary data suggests potential application of sIFN-gammaR as a diagnostic marker in diarrhea-positive HUS.

Conclusions:

  • Age-matched controls are essential for accurate interpretation of serum sIFN-gammaR levels in pediatric patients.
  • Establishing pediatric reference ranges for sIFN-gammaR is critical for its clinical application.
  • Further research is warranted to validate sIFN-gammaR as a diagnostic tool for pediatric HUS.